The name is absent



Table A3.2 - Random Effects results, using a logistic transformation

_________Moo

dy’s___________

__________S&P_________

_______________Fit

ch_____________

(1)

(2)

(3)

(4)

(5)

(6)

Constant

-1.267

-0.379**

-0.012

-2.157**

-1.050

0.027

(-0.74)

(-2.55)

(-0.01)

(-2.31)

(-0.46)

(0.11)

GDP per capita

0.764***

0.788***

0.585***

0.683***

0.654***

0.665***

(6.39)

(8.11)

(5.60)

(10.31)

(7.52)

(7.92)

GDP per capita Avg.

0.172

0.183

0.246**

0.100

(0.84)

(0.94)

(2.06)

(0.38)

GDP growth

0.593

0.147

-0.781

(0.41)

(0.13)

(-0.65)

GDP growth Avg.

-1.388

-5.525

-1.368

(-0.25)

(-1.33)

(-0.18)

Unemployment

-0.028**

-0.024**

0.007

-0.013

(-2.11)

(-1.99)

(0.67)

(-1.08)

Unemployment Avg.

-0.015

-0.004

0.019

(-0.84)

(-0.24)

(0.80)

Inflation

-0.089***

-0.072*

-0.089***

-0.098***

-0.044

(-3.33)

(-1.88)

(-4.35)

(-4.54)

(-1.21)

Inflation Avg.

-0.118

-0.113

-0.102***

-0.016

(-1.30)

(-1.48)

(-3.47)

(-0.15)

Gov Debt

-0.008***

-0.006**

-0.020***

-0.018***

-0.013***

-0.014***

(-2.94)

(-2.33)

(-8.99)

(-11.29)

(-4.81)

(-6.35)

Gov Debt Avg.

-0.007***

-0.005*

-0.007**

-0.006***

-0.009**

-0.007**

(-2.81)

(-1.92)

(-2.24)

(-2.93)

(-2.10)

(-2.18)

Gov Balance

3.380***

3.070***

1.989**

1.576*

1.910

1.901*

(2.60)

(3.11)

(2.00)

(1.76)

(1.63)

(1.66)

Gov Balance Avg.

1.866

-1.946

-1.152

(0.57)

(-0.47)

(-0.32)

Gov Effectiveness

0.107

0.163*

0.105

0.182***

0.262***

0.229***

(0.92)

(1.70)

(1.32)

(2.62)

(2.92)

(2.67)

Gov Effectiveness Avg.

0.714***

1.030***

1.001***

0.910***

0.832***

0.841***

(3.32)

(8.42)

(4.20)

(5.16)

(2.93)

(4.75)

External Debt

0.000

-0.001

-0.002**

-0.001*

(-0.28)

(-1.08)

(-2.12)

(-1.66)

External Debt Avg.

0.000

-0.002

-0.003

-0.003

(0.12)

(-1.07)

(-1.44)

(-1.58)

Current Account

-2.331**

-1.791**

0.195

0.054

(-2.49)

(-2.47)

(0.30)

(0.05)

Current Account Avg.

1.943

3.980**

3.785**

4.778***

4.955**

5.275**

(1.09)

(2.03)

(2.09)

(3.26)

(2.26)

(2.44)

Reserves

0.798***

-0.048

-0.120

(3.60)

(-0.29)

(-0.66)

Reserves Avg.

0.070

0.597***

0.183

0.753

(0.16)

(3.10)

(0.35)

(1.51)

Def 1

-1.044***

-1.096***

-0.561***

-0.465***

-0.510***

-0.566***

(-7.24)

(-8.18)

(-3.53)

(-4.13)

(-2.85)

(-3.38)

Def 2

0.051***

0.047***

0.021

0.072**

0.062***

(2.12)

(2.27)

(0.70)

(2.15)

(1.99)

EU

0.325***

0.234***

0.060

0.109

0.103

(3.23)

(2.92)

(0.88)

(1.30)

(1.41)

IND

1.323***

1.371***

1.255***

0.940***

1.177***

1.277***

(4.42)

(6.19)

(3.54)

(4.76)

(2.73)

(4.07)

LAC

-0.304*

-0.003

-0.332**

-0.318

(-1.72)

(-0.01)

(-2.16)

(-1.28)

R2

0.921

0.910

0.914

0.905

0.902

0.902

Countries

66

73

65

74

58

58

Observations

551

655

564

657

480

481

Hausman Test$________

15.43 (0.281)

4.33 (0.959)

15.24 (0.293)

11.86 (0.065)

15.24 (0.292)

9.01 (0.342)

Notes: White diagonal standard errors & covariance (d.f. corrected). The t statistics are in parentheses. *, **, *** - statistically
significant at the 10, 5, and 1 per cent. $ The null is that RE estimation is consistent and therefore preferable to fixed effects. The test
statistic is to be compared to a Qui-Square with 13, 11, 13, 6, 13, 8 degrees of freedom. The p-value is in brackets

62



More intriguing information

1. The name is absent
2. Consumer Networks and Firm Reputation: A First Experimental Investigation
3. Types of Tax Concessions for Promoting Investment in Free Economic and Trade Areas
4. Whatever happened to competition in space agency procurement? The case of NASA
5. The name is absent
6. The geography of collaborative knowledge production: entropy techniques and results for the European Union
7. New Evidence on the Puzzles. Results from Agnostic Identification on Monetary Policy and Exchange Rates.
8. Stakeholder Activism, Managerial Entrenchment, and the Congruence of Interests between Shareholders and Stakeholders
9. SOME ISSUES IN LAND TENURE, OWNERSHIP AND CONTROL IN DISPERSED VS. CONCENTRATED AGRICULTURE
10. Synthesis and biological activity of α-galactosyl ceramide KRN7000 and galactosyl (α1→2) galactosyl ceramide